| Role |
Name |
Disclosure |
Details |
| Author | Edward J Zabawski Jr, DO, RPh, Dermatology, Spencer Dermatology Group, Crawfordsville, Indiana | Nothing to disclose | Details | | Coauthor | Clay J Cockerell, MD, Director, Clinical Professor, Department of Dermatology, Division of Dermatopathology, University of Texas Southwestern Medical Center | Nothing to disclose | Details | | Medical Editor | Donald Belsito, MD, Clinical Professor, Department of Internal Medicine, Division of Dermatology, University of Missouri at Kansas City; Private Practice, American Dermatology Associates, LLC | Nothing to disclose | Details | | Pharmacy Editor | Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA | Nothing to disclose | Details | | Managing Editor | Julia R Nunley, MD, Professor, Program Director, Dermatology Residency, Department of Dermatology, Virginia Commonwealth University Medical Center | Johnson and Johnson Amgen Forest Lab, Inc Galaxo Smith Klein Covidien Novartis Biolex | Details | | CME Editor | Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University | Nothing to disclose | Details | | Chief Editor | Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Clay J Cockerell, Coauthor |
The contributor discloses no conflict of interest. |
|